What question did this study set out to answer?

This study aims to analyze how different lipoproteins contribute to the degradation of platelet-activating factor (PAF) in human serum.

April 24, 2009Haemostasis

The Contribution of Individual Lipoproteins to the Degradation of Platelet-Activating Factor in Human Serum

View Full Paper

Ask AI

Bookmark

Population

12 healthy volunteers (serum samples)

Design

Other

Authors

GOG OstermannMedizinische Akademie Erfurt GKGerhard M. KostnerMedical University of Graz AGAnna GriesAustrian Academy of Sciences

Discussion

Member takes

Implication

Highlights lipoprotein-dominant PAF degradation in healthy serum; hypothesis-generating for atherothrombotic roles, no practice change indicated.

Key Points

This study aims to analyze how different lipoproteins contribute to the degradation of platelet-activating factor (PAF) in human serum.
Measured PAF-acetylhydrolase activity in serum from 12 healthy volunteers.
Isolated VLDL, LDL, Lp(a), and HDL to assess enzymatic activity and kinetic properties.
Determined maximum velocity (67.2 nmol/min X ml) and Km (15.8 mumol/l) for the degradation of PAF.
Over 90% of PAF-acetylhydrolase activity was associated with lipoproteins.
VLDL and LDL exhibited significantly higher PAF uptake compared to HDL, 5 and 2.5 times respectively.
Distinct kinetic properties of lipoprotein-associated PAF-acetylhydrolase suggest a non-proportional contribution to PAF degradation.

Structured PICO

Population

12 healthy volunteers (serum samples)

Outcome

PAF-acetylhydrolase activity and its association with individual lipoproteinssurrogate

The degradation of platelet-activating factor in human serum depends primarily on PAF-acetylhydrolase bound to apoprotein B-containing lipoproteins (VLDL and LDL).

Cite This Study

Ostermann et al. (2009) studied this question.

synapsesocial.com/papers/6a6fa01926a7f98052dc4087 https://doi.org/10.1159/000215910

Topics

Sermorelin

View Full Paper

Ask AI

Bookmark

Implication

Highlights lipoprotein-dominant PAF degradation in healthy serum; hypothesis-generating for atherothrombotic roles, no practice change indicated.

The Contribution of Individual Lipoproteins to the Degradation of Platelet-Activating Factor in Human Serum

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Topics

The Contribution of Individual Lipoproteins to the Degradation of Platelet-Activating Factor in Human Serum

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider